MHRA paediatric investigation plan
Ruby-Fill (strontium-82 chloride/ rubidium-82 chloride)
MHRA paediatric investigation plan MHRA-100562-PIP01-22 · Modification
Key facts
| PIP number | MHRA-100562-PIP01-22 |
|---|---|
| Product names | Ruby-Fill |
| Active substances | strontium-82 chloride/ rubidium-82 chloride |
| Therapeutic areas | Cardiovascular Diseases, Diagnostic |
| Conditions | Visualisation of myocardial perfusion for diagnostic purposes |
| Decision | PM: decision on the application for modification of an agreed paediatric investigation plan. |
| Published | Apr 30, 2024 |
| MHRA record | cms.mhra.gov.uk |
About MHRA paediatric investigation plans
A paediatric investigation plan sets out the studies a company must run in children to support authorisation of a medicine in the UK, or records a waiver or deferral.
Source: UK Medicines and Healthcare products Regulatory Agency (MHRA). Contains public sector information licensed under the Open Government Licence v3.0 · Source date: